Virus News and Research

Latest Virus News and Research

New study explains why Delta is so easily transmitted and infects people quickly

The Delta variant of SARS-CoV-2 has swept the globe, becoming the dominant variant within just a few months. A new study from Boston Children's Hospital, published today in Science, explains why Delta is so easily spread and infects people so quickly, and suggests a more targeted strategy for developing future COVID-19 vaccines and treatments.

27 Oct 2021

Postpartum women's experience of social restrictions during COVID-19

A new study published on the medRxiv* preprint server has focused on the effect of various social restrictions or lack of social support on women who delivered and raised babies during the pandemic.

27 Oct 2021

Moderna’s COVID-19 vaccine provides durable protection against SARS-CoV-2 delta in macaques

Researchers in the United States have conducted a study showing that Moderna’s coronavirus disease 2019 (COVID-19) vaccine provided durable protection against the B.1.617.2 (delta) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in rhesus macaques.

26 Oct 2021

Cholesterol-lowering drugs not helpful in reducing COVID-related mortality or severity

In the worldwide effort to battle SARS-CoV-2, the virus that causes COVID-19, researchers have often turned to medications used as therapies for other conditions in the hopes of finding ones that either kill the coronavirus or lessen the impacts from its infection.

26 Oct 2021

Simple blood test useful for excluding pulmonary embolism among hospitalized COVID-19 patients

A screening blood test originally validated in seriously ill patients without COVID-19 is still clinically useful for ruling out pulmonary embolism in patients hospitalized with the coronavirus, a University of South Florida Health (USF Health) Morsani College of Medicine research team reports.

26 Oct 2021

A high-throughput pipeline for identifying nanobodies that target and neutralize SARS-CoV-2

Researchers in the United States have developed a cost-effective, high-throughput pipeline for identifying effective nanobodies that target and neutralize severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).

26 Oct 2021

Extending COVID-19 vaccinations to adolescents and children may lower the overall disease burden

A recent study by researchers from the Netherlands highlights that the introduction of vaccination programs against coronavirus disease 2019 (COVID-19) to adolescents and children may reduce infection rates and severe disease outcomes – both in these age groups and in the population as a whole. The paper is currently available on medRxiv* preprint server while it undergoes peer review.

26 Oct 2021

HCV treatment decreases protein activity levels involved in liver cirrhosis, research shows

Researchers at the Medical University of South Carolina report in the Journal of Viral Hepatitis that the activity levels of the proteins involved in liver scarring, or cirrhosis, begin to decrease immediately after treatment for the hepatitis C virus (HCV), suggesting the possibility of early healing.

26 Oct 2021

Hyperimmune antibody produced in horses may be an efficient approach to combat covid-19

A study conducted by a consortium of Brazilian researchers has demonstrated that a hyperimmune serum consisting of purified antibody fragments produced in horses may be an efficient approach to combat covid-19.

26 Oct 2021

Model suggests longer protection from SARS-CoV-2 neutralizing antibody response

A new study discusses the durability of the immune response following natural infection or vaccination.

26 Oct 2021

Effectiveness of mRNA BNT162b2 COVID-19 vaccine in immunocompromised individuals

Israeli researchers evaluate the antibody response in ICPs to assess antibody-mediated immunity following vaccination with the Pfizer-BioNTech vaccine.

26 Oct 2021

UQ researchers find that SARS-CoV-2 virus does not infect blood vessels

The SARS-CoV-2 virus does not infect blood vessels, despite the high risk of blood clots to COVID-19 patients, University of Queensland researchers have found.

26 Oct 2021

Attitudes towards COVID-19 vaccination amongst essential workers

A new study has addressed these gaps in knowledge regarding the uptake of COVID-19 vaccines among essential workers.

26 Oct 2021

Evaluation of COVID-19 infection risk during US spring semester in-person teaching

The main objective of the study was to determine the rates of in-person schooling and understand the school-based mitigation measures that were modified over the semester.

26 Oct 2021

Identification of long COVID patients using big data

A new preprint exploits big data to come up with some answers as to the incidence, treatment, and impact on healthcare systems of long covid.

26 Oct 2021

High and increasing SARS-CoV-2 infection prevalence amongst school-aged children in England

The latest round of the REACT-1 study indicates SARS-CoV-2 continues to spread among children.

26 Oct 2021

Sexually dimorphic placental antibody transfer during SARS-CoV-2 infection

In a paper recently published in the journal Science Translational Medicine by Bordt et al. (October 19th, 2021), maternal SARS-CoV-2 infections are studied with particular regard to maternal-fetal antibody transfer and virus-induced placental interferon responses, finding a sexually dimorphic response that results in lesser antibody transfer to the male fetus.

26 Oct 2021

Water and surface surveillance can detect 93% of school-based COVID-19 cases

A new study posted to the medRxiv* preprint server explores environmental surveillance of elementary school settings for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) through wastewater and surface samples monitoring. The researchers demonstrated that 93% of the COVID-19 cases in public elementary schools could be identified using this method.

25 Oct 2021

SARS-CoV-2 delta variant generates infections more quickly than previous strains

Researchers in the UK have conducted a study suggesting that the B.1.617.2 (delta) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19) – is transmitted more quickly than previously circulating variants.

25 Oct 2021

COVID-19's impact on excess mortality in 2020 varied widely across Europe

A team of researchers has demonstrated that the impact of the coronavirus disease 2019 (COVID-19) pandemic on excess mortality varied widely both between and within five European countries in 2020.

25 Oct 2021

Virus News and Research

Latest Virus News and Research

New study explains why Delta is so easily transmitted and infects people quickly

Postpartum women's experience of social restrictions during COVID-19

Moderna’s COVID-19 vaccine provides durable protection against SARS-CoV-2 delta in macaques

Cholesterol-lowering drugs not helpful in reducing COVID-related mortality or severity

Simple blood test useful for excluding pulmonary embolism among hospitalized COVID-19 patients

A high-throughput pipeline for identifying nanobodies that target and neutralize SARS-CoV-2

Extending COVID-19 vaccinations to adolescents and children may lower the overall disease burden

HCV treatment decreases protein activity levels involved in liver cirrhosis, research shows

Hyperimmune antibody produced in horses may be an efficient approach to combat covid-19

Model suggests longer protection from SARS-CoV-2 neutralizing antibody response

Effectiveness of mRNA BNT162b2 COVID-19 vaccine in immunocompromised individuals

UQ researchers find that SARS-CoV-2 virus does not infect blood vessels

Attitudes towards COVID-19 vaccination amongst essential workers

Evaluation of COVID-19 infection risk during US spring semester in-person teaching

Identification of long COVID patients using big data

High and increasing SARS-CoV-2 infection prevalence amongst school-aged children in England

Sexually dimorphic placental antibody transfer during SARS-CoV-2 infection

Water and surface surveillance can detect 93% of school-based COVID-19 cases

SARS-CoV-2 delta variant generates infections more quickly than previous strains

COVID-19's impact on excess mortality in 2020 varied widely across Europe

A new way of characterising biomolecules eBook

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Newsletters you may be interested in